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ABSTRACT
Objective: The objective of this study was to evaluate the effects of ethyl acetate extract of Mucuna cochinchinensis seeds (EMC) on 
7,12-Dimethylbenzanthracene induced mammary carcinoma in Sprague–Dawley rats and to understand the expression of B-cell lymphoma-2 (Bcl-2) 
an anti-apoptotic protein in experimental animals tissues.
Methods: The antitumor activity was accessed by the effects of EMC on tumor weight, body weight, enzymic, and non-enzymic antioxidant 
parameters such as thiobarbituric acid reactive substances in plasma, superoxide dismutase, glutathione peroxidase, reduced glutathione (GSH), 
catalase, vitamin C and vitamin E in breast tissues and serum. The extract was administered orally at three different doses of low (200 mg/kg), high 
(400 mg/kg), and low dose with the standard. Western blot analysis was carried out for understanding Bcl-2 expressions. EMC was analyzed by high-
performance liquid chromatography (HPLC)/electron spray ionization (ESI)- mass spectrometry (MS) to comprehend the active constituents.
Results: Significant (p<0.01) reduction in tumor weight and gain in body weight were observed with EMC treatment. Enzymic and non-enzymic 
antioxidant levels in serum as well in breast tissues were revert back significantly (p<0.01) on EMC treatment. Overexpression of Bcl-2 was observed 
in tumor control and intensities were reduced in the treatment group. HPLC/ESI-MS revealed the presence of genistein and daidzein.
Conclusion: The EMC seeds shown anticancer activity in tested animal model.
Keywords: Mucuna cochinchinensis, Isoflavones, 7,12-Dimethyl benzanthracene, Mammary carcinoma, Liquid chromatography-mass spectrometry.
INTRODUCTION
Several epidemiologic and animal model studies suggested that dietary 
or herbal chemicals remove or alleviate cancer by their antioxidant 
property leading to apoptosis [1]. Breast cancer emerged as the second 
most lethal threat to human beings and the current treatment pattern 
pose risk in the development of multiple complications. Natural 
resources promise a safe way of combating cancer symptoms.
Mucuna (Leguminosae) is an annual twinning herb, used as food and 
fodder by various ethnic groups [2]. Mucuna has medicinal properties 
such as antioxidant, antiparkinson, antidiabetic, aphrodisiac, antivenom, 
antibacterial, and antitumor [3-8]. L-dopa is the major constituent 
found in Mucuna responsible for antiparkinson’s activity [9]. Apart 
from L-dopa, few alkaloids and lipid derivatives were also reported 
in Mucuna [10,11]. Genistein and daidzein were the main isoflavones 
responsible for the antioxidant activity present in soybean and Mucuna 
and the total daidzein and genistein in Mucuna was found to be higher 
than in soybeans [12]. Soy proved to prevent and treat breast cancers 
due to its rich content of phytoestrogen: Genistein [13]. Mucuna is still 
underexplored in spite of having rich possible benefits as antibreast 
cancer agent. Above background prompted us to pursue the antitumor 
activity by understanding the effects of ethyl acetate extract of Mucuna 
cochinchinensis (EMC) seed on chemical induced breast carcinoma in 
rat models.
METHODS
Extraction and phytochemical screening
M. cochinchinensis seeds were collected from Western Ghats, Tamil Nadu, 
India and were identified and authenticated by renowned Botanist. 
A voucher specimen was kept in our Herbarium (UCP/11/031). The 
seeds were dried in shade and powdered in a mechanical grinder. 
About 250 g of dried seed powder was extracted by cold maceration 
using shaker for 72 hrs in 1.0 L ethyl acetate, concentrated in a rotary 
vacuum evaporator and the yield was found to be 4.3% w/w. The EMC 
was subjected to phytochemical screening for the presence of alkaloids, 
saponins, glycosides, carbohydrates, tannins, flavonoids, steroids, and 
triterpenoids [14].
Liquid chromatography-mass spectrometry (LC-MS) analysis
A qualitative analysis for compounds present in EMC was performed 
by LC, electron spray ionization (ESI), MS LC-ESI(MS)/MS using Bruker 
UHPLC 3000 chromatograph coupled to a quadrupole-ToF mass 
selective detector (microToF QII, Bruker, Germany). Chromatographic 
separation of the extract was done using RP C18 column (100 
mm×3.9 mm with an internal diameter of 5 μm, Acclaim®, Sunnyvale, 
CA, USA). Gradient elution was performed using a mobile phase A 
represented by acetonitrile and mobile phase B represented by Milli-Q 
water acidified with acetic acid (2%) with the following gradient 
profile: Initially, 95% B to 80% B over 5 minutes; to 70% B over 
5 minutes; to 65% B over 5 minutes; to 40% B over 5 minutes; to 0% 
B over 5 minutes; to 95% B over 2.5 minutes and continuing at 95% B 
until completion of the run. Flow rate was set to 200 μL/min and Ultra 
violet absorbance was detected at 335 nm. Mass spectra in negative 
ion mode were generated. The constituents were identified from 
high-performance liquid chromatography (HPLC) – MS/MS technique 
and the structures of the same were obtained from PubChem small 
molecular database [15].
Animals and drugs
Female Sprague–Dawley rats weighing (220±5 g) were procured from 
central animal house, K.M. College of Pharmacy, Madurai, Tamil Nadu, 
India. The animals were housed in well ventilated large spacious 
polypropylene cages and had 12±1 hr light and dark cycle throughout 
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the experimental period. The animals received a balanced diet of 
commercially available pellet rat feed and water ad-libitum. EMC and 
tamoxifen dissolved in corn oil and administered intragastrically 
(Approval - IAEC/KMCP/2013/93).
Tumor induction
Mammary tumor was induced by a single dose of 20 mg of 7,12-Dimethyl 
benzanthracene (DMBA) dissolved in corn oil (1 ml) given through an oral 
gavage [16]. All the experimental animals were sacrificed after 90 days.
Experimental design
A total of 36 female Sprague–Dawley rats were divided into six groups 
of six rats each. Group I received normal saline (10 ml/kg body 
weight), Group II tumor control, Group III received standard tamoxifen 
(10 mg/kg body weight), Group IV received EMC (200 mg/kg body 
weight) and tamoxifen (10 mg/kg body weight), Group V and Group VI 
received EMC 200 and 400 mg/kg body weight, respectively. At the end 
of the experimental period, all the rats were alive and were anesthetized 
with diethyl ether and sacrificed by euthanasia. Animals were starved 
overnight before sacrifice. Blood was collected and the serum was 
separated by centrifugation. Breast was dissected out and washed with 
ice-cold 0.9% NaCl solution. The resultant solid tumor was considered 
to be prelate ellipsoid with one long axis and two short axes. The two 
short axes were measured with a vernier caliper. The tumor weight [17] 
was calculated using the following formula:
( ) ( ) ( )
×
=
Length cm Width 2 cm
Weight g
2
Tissues (100 mg) were homogenized in 0.1 M Tris–HCl buffer (pH 7.4). 
The homogenate was used for the determination of various antioxidant 
biochemical parameters.
Biochemical analysis
The superoxide dismutase (SOD) activity was measured at absorbance 
420 nm using a spectrophotometer as the degree of inhibition of 
autoxidation of pyrogallol in an alkaline pH according to the method of 
Marklund and Marklund [18]. The catalase (CAT) activity was assayed 
by the method of Sinha [19]. The activity of glutathione peroxidase (GPx) 
was assayed by the method of Rotruck et al. [20]. Reduced glutathione 
(GSH) was determined by the method of Moron et al. [21]. Vitamin E 
(a-tocopherol) levels were estimated by the method of Desai [22]. Vitamin 
C (ascorbic acid) was measured by the method of Omaye et al. [23]. Lipid 
peroxidation was estimated by the method of Högberg et al. [24].
Western blot analysis
Tumors were disaggregated by treatment with an enzymic mixture 
containing 2.0 g/l collagenase, 0.5 g/l proteases, and 2.0 g/l DNase for 
90 minutes at 37°C. The resulting cell suspensions were filtered through 
a 30 μm nylon mesh. Centrifuged cells were washed in phosphate-
buffered saline and boiled in Laemmli lysis buffer for 5 minutes. Breast 
tissue proteins (50 μg/lane) were separated on 12% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to nitrocellulose membrane. The membrane was probed with B-cell 
lymphoma-2 (Bcl-2) specific antibody (1:2000 dilution) to determine 
their levels, and the intensities were measured using ImageJ/Fiji 1.46. 
β-actin was used as an internal control [25].
Statistical analysis
The treated groups were compared with the toxicant control groups. 
All results were expressed as a mean±standard error of the mean of 
six animals in each group. The results were analyzed statistically using 
one-way ANOVA followed by Newman-Keuls multiple comparison 
methods to compare the mean value of different groups using Graph 
pad 3.1 version. p<0.05 was considered significant.
RESULTS
EMC screened for phytoconstituent analysis revealed the presence of 
alkaloids, phenols, flavonoids, amino acids, quinones, steroids, and 
carbohydrate in various color reactions. The characterizations of the 
compounds using UHPLC ESI MS/MS analysis were done in negative 
ion mode. To confirm the nature of the flavonoid peaks observed in the 
EMC, MS/MS experiments were carried out to obtain the characteristic 
fragments of each peak. The data of typical MS/MS spectra of each type 
are shown in Fig. 1. Common features such as CO and CO2 losses for 
the flavonoids were observed as a result of the contraction of ring C. 
Diagnostic fragments were observed for each type of the flavonoids. 
For example, significant Retro-Diels-Alder fragments such as Aion were 
obtained for isoflavones. For the isoflavones, Genistein and Daidzein, 
the ion loss of C3O2 was observed. This was attributed to the Diels-
Alder fragmentation reaction between rings A and C [26]. Further the 
strong intense peak at 241, 225, 197, 181 m/z confirmed the structure 
of genistein, while 209, 181, 135 confirmed the presence of daidzein.
Table 1 presents the body weight, tumor weight and thiobarbituric 
acid-reactant substances of control and experimental animals. The 
body weight was found to be significantly decreased in Group II tumor-
induced animals when compared with control animals (p<0.01). 
Conversely, the administration of EMC increased the body weight 
in Group III to VI when compared to Group II animals (p<0.01). The 
Groups III to IV animals exhibited significant (p<0.01) reduction of 
tumor weight when compared to Group II. The Groups V to VI animals 
exhibited significant (p<0.05) reduction of tumor weight when 
compared to Group II. Administration of EMC decreased the tumor 
weight significantly (p<0.05).
Activities of enzymic and non-enzymic antioxidants in breast 
homogenate and serum of control and experimental animals are 
presented in Tables 2 and 3, respectively. Group II cancer-bearing 
animals showed a significant reduction in both enzymic and non-
enzymic antioxidant levels (p<0.01) when compared to control 
animals. Administration of tamoxifen and EMC in Groups III to VI 
animals significantly (p<0.01) increased the antioxidant levels when 
compared to Group II animals. Striking results were observed for body 
Table 1: Effect of EMC on body weight and tumor weight of 







I 220.30±9.25 - 0.28±0.03
II 145.55±5.85*a 6.15±0.32 0.09±0.01*b
III 185.40±6.08*b 2.65±0.24*b 0.24±0.02*b
IV 198.30±6.15*b 2.40±0.20*b 0.26±0.03*b
V 189.70±6.25*b 3.30±0.28*b 0.19±0.02*b
VI 195.40±6.40*b 3.05±0.24*b 0.22±0.02*b
Values are expressed as mean±SEM. All values were find out by using 
one-way ANOVA followed by Newman-Kevls multiple range tests. *aValues are 
significantly different from normal control at p <0.01. *bValues are significantly 
different from breast cancer control at p <0.01. TBARS: Thiobarbituric 
acid reactive substances, EMC: Ethyl acetate extract of Mucuna 
cochinchinensis,   SEM: Standard error of mean
Fig. 1: Liquid chromatography (LC), mass spectrometry (MS) 
LC-MS identification of constituents of Mucuna cochinchinensis 
ethyl acetate extract. (a) LC-MS spectrum of genistein. [M-H]− m/z 
– 269.1 g/mol. Fragments - 241, 225, 213, 197, 183, 181, 159, 133, 
151, 113. RT - 5.35 minutes. MF - C15H10O5. (b) LC-MS spectrum of 
daidzein. [M-H]− m/z – 255.1 g/mol. Fragments - 209, 197, 181, 
133, 116. RT - 3.7 min. MF - C15H10O4
ba
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weight, enzymic and non-enzymic parameters for Group IV, by which 
the combined efficacy of standard and EMC at low dose is understood.
To assess the expression of Bcl-2 in breast tissues of experimental 
animals, SDS-PAGE and Western blot analysis were performed. Bcl-2 
proteins were expressed in all the experimental animals and expressed 
in (Fig. 2). Intensities observed of treated and normal groups were 
significantly different from Group II. Group IV intensity demonstrated 
an excellent silencing of Bcl-2 expression in combined treatment 
pattern of standard and extract even with EMC treated alone. Genistein 
and Daidzein present in the extract are very much responsible for 
downregulating the bcl-2 gene.
DISCUSSION
Recent studies indicated that the use of HPLC and coupled techniques, 
such as ESI or diode array detector and mass spectra, is a powerful 
approach for the rapid identification of the constituents in medicinal 
plants and their preparations [27]. In this study for the qualitative 
analysis, acetonitrile, aqueous acetic acid was used as the suitable 
eluting solvent for the analysis of flavonoids in (EMC). The compounds 
were confirmed by small molecular databases and further fragmentation 
pattern was analyzed through previous studies.
The present study indicates that administration of plant extract 
resulted in substantial inhibition of breast tumor incidence or decrease 
in the initiation of tumor genesis and increase in body weight of animals 
treated with EMC at a dose of 200 mg/kg and 400 mg/kg body weight.
Toxic manifestation of DMBA is associated with its oxidative metabolism 
leading to the formation of reactive metabolites (epoxides and quinines) 
capable of generating free radicals. Metabolism of DMBA by the mixed 
function oxidases system often results in the formation of oxyradicals 
which bind covalently to nucleophillic sites on cellular macromolecules 
thereby eliciting cancerous responses [28]. The generation of reactive 
oxygen species (ROS) and the peroxidation of membrane lipids are 
well associated with the initiation of carcinogenesis affecting the 
normal biochemical process, which further leads to the reduction of 
body weight [29]. Naturally, there is a dynamic balance between the 
amount of free radicals generated in the body and antioxidant defense 
system that quench or scavenge them and thereby protect the body 
against pathogenesis [30]. It is evident from the results that increased 
the level of lipid peroxides (LPO) was found in cancer-bearing animals 
when compared to control group. On the contrary, reduced level of LPO 
was observed in tamoxifen and EMC treated animals at both doses 
indicating that it is a good free radical scavenger. SOD and CAT act 
mutually supportive antioxidative enzymes, which provide protective 
defense against ROS [31]. The present study reveals that SOD levels are 
decreased in the cancer-bearing animal, which may be due to altered 
antioxidant status caused by carcinogenesis. The present study also 
shows that decreased level of CAT observed in Group II cancer-bearing 
animals may be due to the utilization of antioxidant enzymes in the 
removal of H2O2 by DMBA.
GPx is an important defense enzyme against oxidative damage and this, 
in turn, requires GHS as a cofactor. GPx catalyses the oxidation of GSH 
using H2O2 [32]. Our findings agree well with this observation and also 
the activity of GPx significantly decreased in cancer-bearing animals.
The non-enzymic antioxidant systems are the second line of defense 
against free radical damage. GSH is an important non-protein cellular 
thiol that in conjunction with GPx plays a regulatory role in cell 
proliferation [33]. We observed decreased activity of GSH in cancer-
bearing animals. The EMC increased the GSH levels, which clearly 
suggest their antioxidant property. Decreased levels of water soluble 
antioxidants found in cancer-bearing animal may be due to the 
utilization of antioxidants to scavenge the free radicals.
Vitamin E is a potent oxygen radical scavenger that protects cell 
membranes from oxidative damage initiated by carcinogens [34]. The 
present study found decreased levels of vitamin E in the cancer condition 
which may be due to excessive production of ROS by cancer cells. The 
free radical clearing capacity of vitamin E is due to the localization of an 
unpaired electron on its conjugated double bond. Thus, it is suggested 
that the occurrence of phytochemicals such as daidzein and genistein in 
EMC significantly attenuated the LPO activity and resulted in increased 
antioxidant levels.
The apoptotic signal transduction pathway commonly induced by 
anticancer agents is associated with the induction of Bax and cleaved 
PARP and the downregulation of Bcl-2 and pAkt. Bcl-2 expression is 
Table 2 : Effect of EMC on enzyme and non-enzyme antioxidants in breast homogenate for control and experimental animals
Groups SOD (U/min/mg 
protein)






Vitamin C (μg/mg 
protein)
Vitamin E (μg/mg 
protein)
I 16.35±1.70 69.15±1.88 12.85±0.80 13.12±0.96 3.60±0.35 5.32±0.53
II 7.78±0.65*a 43.60±1.32*a 6.92±0.65*a 6.28±0.71*a 1.58±0.20*a 3.42±0.26*a
III 15.28±0.86*b 68.64±1.74*b 12.60±0.72*b 12.88±0.80*b 3.36±0.30*b 5.18±0.46*b
IV 15.66±0.92*b 68.78±1.76*b 12.71±0.76*b 12.96±0.86*b 3.44±0.32*b 5.24±0.48*b
V 15.15±0.80*b 67.95±1.48*b 11.95±0.68*b 12.12±0.66*b 3.15±0.24*b 4.96±0.36*b
VI 15.48±0.88*b 68.18±1.56*b 12.42±0.74*b 12.62±0.78*b 3.30±0.28*b 5.05±0.38*b
Values are expressed as mean±SEM. All values were find out by using one-way ANOVA followed by Newman-Kevls multiple range tests. *aValues are significantly 
different from normal control at p <0.01. *bValues are significantly different from breast cancer control at p <0.01. EMC: Ethyl acetate extract of Mucuna cochinchinensis,      
SEM: Standard error of mean, SOD: Superoxide dismutase, CAT: Catalase, GPx: Glutathione peroxidase, GSH: Reduced glutathione
Table 3: Effect of EMC on enzyme and non-enzyme antioxidants in serum for control and experimental animals
Groups SOD (U/min/mg 
protein)






Vitamin C (μg/mg 
protein)
Vitamin E (μg/mg 
protein)
I 12.10±1.40 63.22±3.50 9.68±1.20 10.82±1.08 2.95±0.08 5.08±0.48
II 9.05±0.92*a 34.60±2.45*a 6.86±0.88*a 7.22±0.72*a 1.58±0.06*a 3.36±0.30*a
III 11.76±1.08*b 57.45±3.12*b 9.12±1.02*b 10.18±0.92*b 2.68±0.07*b 4.48±0.36*b
IV 11.89±1.18*b 59.20±3.20*b 9.18±1.08*b 10.44±0.98*b 2.79±0.08*b 4.54±0.40*b
V 11.26±1.05*b 51.66±2.96*b 8.44±0.96*b 9.30±0.82*b 2.26±0.06*b 4.16±0.31*b
VI 11.56±1.14*b 54.34±3.08*b 8.92±1.0*b 9.86±0.94*b 2.48±0.07*b 4.32±0.32*b
Values are expressed as mean±SEM. All values were find out by using one-way ANOVA followed by Newman Kevls multiple range tests. *aValues are significantly 
different from normal control at p <0.01. *bValues are significantly different from breast cancer control at p <0.01. EMC: Ethyl acetate extract of Mucuna cochinchinensis, 
SEM:  Standard error of mean, SOD: Superoxide dismutase, CAT: Catalase, GPx: Glutathione peroxidase, GSH: Reduced glutathione
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regulated by the ER-responsive element of the promoter region of the 
bcl-2 gene [35], such that overexpression of Bcl-2 might be expected to 
confer greater drug resistance on ER-positive breast cancer cells. Some 
reports suggest that Bcl-xL, but not Bcl-2, is capable of modulating 
apoptosis induced by tumor necrosis factor related apoptosis ligand. 
Usually, the downregulation of Bcl-2 expression by AS Bcl-2 enhances 
drug sensitivity by modulating the apoptotic signal transduction 
pathway of Bcl-2 [36]. However, Bcl-2 inhibits Bid-induced apoptosis at 
the mitochondrial level by blocking cytochome c release, whereas Bcl-xL 
does not affect the insertion of tBid into mitochondrial membranes [37]. 
So in this study, Bcl-2 is concentrated rather than any other member of 
the same family. Overexpression of Bcl-2 is observed more frequently 
than overexpression of Bcl-xL (70% vs. 40%) in breast cancer tissue, 
which suggests a more important role for Bcl-2 in conferring drug 
resistance. In our results greater suppression of Bcl-2 was achieved.
CONCLUSION
The biochemical alterations observed in cancer-bearing animals in 
the present study may be due to the induction of LPO and reduction 
of antioxidant level following carcinogen administration. However, 
administration of EMC significantly reversed the alteration to near 
normal level in cancer-bearing animals. From the results, it can be 
inferred that EMC positively modulated the antioxidant activity by 
quenching and detoxifying the free radicals induced by DMBA. The 
attenuation of DMBA induced oxidative stress by the plant extract 
could be attributed to the antioxidants activity of isoflavones (genistein 
and daidzein) present in the Mucuna, which is known to quench the 
free radicals by maintaining antioxidants levels and induce apoptosis 
also by downregulating antiapoptotic protein Bcl-2. Considering these 
properties of Mucuna, the extract can be supplemented with anticancer 
medicines.
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